{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:34:28Z","timestamp":1782603268698,"version":"3.54.5"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> COVID-19-associated muscular complications may comprise myalgia, weakness, wasting, and rhabdomyolysis. Skeletal muscle damage in COVID-19 may be due to direct infection by the virus SARS-CoV-2 through interaction with the ACE2 receptor, systemic hyper-inflammatory state with cytokine release and homeostatic perturbation, an autoimmune process, or myotoxic drugs. Disclosing the cause of weakness in an individual patient is therefore difficult.<\/jats:p><jats:p><jats:bold>Case Description:<\/jats:bold> We report two patients, who survived typical COVID-19 pneumonia requiring intensive care treatment and who developed early on myalgia and severe proximal weakness in all four limbs. Laboratory exams revealed elevated serum creatine kinase and markedly increased C-reactive protein and interleukin 6, concurring with a systemic inflammatory response. On admission in neurorehabilitation (4 and 7 weeks after COVID-19 onset, respectively), the patients presented with proximal flaccid tetraparesis and limb-girdle muscle atrophy. Motor nerve conduction studies showed decreased amplitude and prolonged duration of compound muscle action potentials (CMAPs) with normal distal motor latencies and normal conduction velocities in median and ulnar nerves. Needle electromyography in proximal muscles revealed spontaneous activity in one and myopathic changes in both patients.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> Clinical, laboratory, and electrodiagnostic findings in these patients were unequivocally consistent with myopathy. Interestingly, increased distal CMAP duration has been described in patients with critical illness myopathy (CIM) and reflects slow muscle fiber conduction velocity due to membrane hypo-excitability, possibly induced by inflammatory cytokines. By analogy with CIM, the pathogenesis of COVID-19-related myopathy might also depend on hyperinflammation and metabolic pathways that may affect muscles in a pathophysiological continuum from hypo-excitability to necrosis.<\/jats:p>","DOI":"10.3389\/fneur.2021.625144","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T06:00:36Z","timestamp":1611900036000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Case Report: Myopathy in Critically Ill COVID-19 Patients: A Consequence of Hyperinflammation?"],"prefix":"10.3389","volume":"12","author":[{"given":"Viviana","family":"Versace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sebastianelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Ferrazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopold","family":"Saltuari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kofler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Uncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1007\/s10072-020-04708-8","article-title":"Neuromuscular presentations in patients with COVID-19","volume":"41","author":"Paliwal","year":"2020","journal-title":"Neurol Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1152\/japplphysiol.00321.2020","article-title":"The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies","volume":"129","author":"Ferrandi","year":"2020","journal-title":"J Appl Physiol (1985)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1056\/NEJMc2011400","article-title":"Multiorgan and renal tropism of SARS-CoV-2","volume":"383","author":"Puelles","year":"2020","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1212\/WNL.0000000000009566","article-title":"COVID-19 and neuromuscular disorders","volume":"94","author":"Guidon","year":"2020","journal-title":"Neurology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e781","DOI":"10.1212\/NXI.0000000000000781","article-title":"Guillain-Barr\u00e9 syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: more to come with myositis in the offing","volume":"7","author":"Dalakas","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.clinph.2020.06.003","article-title":"Critical illness myopathy as a consequence of Covid-19 infection","volume":"131","author":"Tankisi","year":"2020","journal-title":"Clin Neurophysiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ijid.2020.07.072","article-title":"Critical illness myopathy after COVID-19","volume":"99","author":"Bagnato","year":"2020","journal-title":"Int J Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1212\/WNL.0000000000010280","article-title":"Acute myopathic quadriplegia in patients with COVID-19 in the intensive care unit","volume":"95","author":"Madia","year":"2020","journal-title":"Neurology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.clinph.2020.09.017","article-title":"Neuromuscular involvement in COVID-19 critically ill patients","volume":"131","author":"Caba\u00f1es-Mart\u00ednez","year":"2020","journal-title":"Clin Neurophysiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.nrleng.2020.07.012","article-title":"Neurological complications in critical patients with COVID-19","volume":"35","author":"Abenza-Abild\u00faa","year":"2020","journal-title":"Neurologia."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00134-020-06244-7","article-title":"Intensive care unit acquired muscle weakness in COVID-19 patients","volume":"46","author":"Van Aerde","year":"2020","journal-title":"Intensive Care Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.clinph.2014.11.027","article-title":"Tokyo Metropolitan Neuromuscular Electrodiagnosis Study, Effects of low frequency filtering on distal compound muscle action potential duration for diagnosis of CIDP: a Japanese-European multicenter prospective study","volume":"126","author":"Mitsuma","year":"2015","journal-title":"Clin Neurophysiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/mus.25732","article-title":"Compound muscle action potential duration in critical illness neuromyopathy","volume":"57","author":"Kramer","year":"2018","journal-title":"Muscle Nerve."},{"key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mus.20884","article-title":"Critical illness myopathy: further evidence from muscle-fiber excitability studies of an acquired channelopathy","volume":"37","author":"Allen","year":"2008","journal-title":"Muscle Nerve."},{"key":"B15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00415-004-0272-z","article-title":"Critical illness myopathy serum fractions affect membrane excitability and intracellular calcium release in mammalian skeletal muscle","volume":"251","author":"Friedrich","year":"2004","journal-title":"J Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1152\/physrev.00028.2014","article-title":"The sick and the weak: neuropathies\/myopathies in the critically ill","volume":"95","author":"Friedrich","year":"2015","journal-title":"Physiol Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun Rev."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.625144\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T06:00:37Z","timestamp":1611900037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.625144\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":17,"alternative-id":["10.3389\/fneur.2021.625144"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.625144","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"article-number":"625144"}}